For some, the weight loss and metabolic benefits of GLP-1 RAs might be the primary driver for mood improvement, whereas for others, a traditional antidepressant might be more directly suited to their specific depressive symptoms
These findings are consistent with data accessed on January 29, 2024
doi:10.1016/j.nutres.2013.07.011 Phimister AJ, Williams KJ, Van Winkle LS, Plopper CG (2005) Consequences of abrupt glutathione depletion in murine Clara cells: ultrastructural and biochemical investigations into the role of glutathione loss in naphthalene cytotoxicity
You should remain on your GLP-1 therapy until your weight loss goal is met
This is where nuance matters
The Bottom Line The shifting regulatory picture is potentially good news for patients who can benefit from carefully managed peptide therapy, depending on what the PCAC review concludes in July